HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicholas W Lange Selected Research

nirmatrelvir and ritonavir drug combination

11/2022COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era.
1/2022Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicholas W Lange Research Topics

Disease

2COVID-19
11/2022 - 01/2022
2Hemorrhage
12/2021 - 05/2021
1Caliciviridae Infections
01/2022
1Thrombosis (Thrombus)
12/2021
1Liver Diseases (Liver Disease)
12/2018
1Renal Insufficiency (Renal Failure)
12/2018

Drug/Important Bio-Agent (IBA)

2nirmatrelvir and ritonavir drug combinationIBA
11/2022 - 01/2022
1sotrovimabIBA
11/2022
1N-(2-cyanoethylene)urea (BA 1)IBA
11/2022
1nitazoxanide (NTZ)FDA Link
01/2022
1apixabanIBA
12/2021
1AnticoagulantsIBA
12/2021
1Hemostatics (Antihemorrhagics)IBA
05/2021
1Calcineurin InhibitorsIBA
12/2018
1BasiliximabFDA Link
12/2018

Therapy/Procedure

2Therapeutics
11/2022 - 12/2021
1Liver Transplantation
12/2018